Cytokinetics, Incorporated · NASDAQ:CYTK

T. Rowe Price Investment Management, Inc. reported a 11.30% stake in Cytokinetics, Incorporated (Schedule 13G)

Event Apr 30, 2025 · Filed May 7, 2025

T. Rowe Price Investment Management, Inc. reported a 11.30% stake in Cytokinetics, Incorporated, 13,420,144 shares, as a passive investor on Apr 30, 2025. Filed May 7, 2025 (Schedule 13G).

Stake
11.30%
Shares
13,420,144
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.11.30%13,420,144

Source

View original at SEC

Related